Related Experiment Video
Updated: May 13, 2026

Imaging pHluorin-tagged Receptor Insertion to the Plasma Membrane in Primary Cultured Mouse Neurons
Published on: November 20, 2012
Towards improved receptor targeting: anterograde transport, internalization and postendocytic trafficking of
Stefanie Babilon1, Karin Mörl, Annette G Beck-Sickinger
1Institute of Biochemistry, Faculty of Biosciences, Pharmacy and Psychology, Leipzig University, Bruderstra se 34, D-04103 Leipzig, Germany.
Abstract:
The neuropeptide Y system is known to be involved in the regulation of many central physiological and pathophysiological processes, such as energy homeostasis, obesity, cancer, mood disorders and epilepsy. Four Y receptor subtypes have been cloned from human tissue (hY1, hY2, hY4 and hY5) that form a multiligand/multireceptor system together with their three peptidic agonists (NPY, PYY and PP). Addressing this system for medical application requires on the one hand detailed information about the receptor-ligand interaction to design subtype-selective compounds. On the other hand comprehensive knowledge about alternative receptor signaling, as well as desensitization, localization and downregulation is crucial to circumvent the development of undesired side-effects and drug resistance. By bringing such knowledge together, highly potent and long-lasting drugs with minimized side-effects can be engineered. Here, current knowledge about Y receptor export, internalization, recycling, and degradation is summarized, with a focus on the human Y receptor subtypes, and is discussed in terms of its impact on therapeutic application.
Insights
Understanding neuropeptide Y (NPY) receptor dynamics like internalization and recycling is key to developing effective drugs. This knowledge helps create potent therapeutics with fewer side effects for conditions like obesity and epilepsy.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- The neuropeptide Y system regulates vital physiological processes including energy homeostasis, obesity, mood disorders, and epilepsy.
- Four human Y receptor subtypes (hY1, hY2, hY4, hY5) interact with NPY, PYY, and PP, forming a complex multiligand/multireceptor system.
Purpose of the Study:
- To summarize current knowledge on the dynamic trafficking of human Y receptor subtypes (export, internalization, recycling, degradation).
- To discuss the impact of receptor dynamics on therapeutic applications and drug development for the neuropeptide Y system.
Main Methods:
- Literature review and synthesis of existing research on Y receptor trafficking.
- Focus on human Y receptor subtypes and their interactions with agonists.
Main Results:
- Detailed understanding of receptor-ligand interactions is essential for designing subtype-selective compounds.
- Knowledge of receptor signaling, desensitization, localization, and downregulation is crucial for minimizing side effects and drug resistance.
Conclusions:
- Engineering potent, long-lasting drugs with minimized side effects requires integrating knowledge of receptor dynamics.
- Understanding Y receptor trafficking is critical for successful therapeutic targeting in various pathophysiological conditions.
Related Concept Videos
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor-mediated Endocytosis
Receptor-Mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Neurochemical Transmission: Sites of Drug Action
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

